Host modulation therapy with anti-inflammatory agents

Keyphrases

• Anti-inflammatory Agents 100%
• Periodontitis Treatment 100%
• Host-directed Therapy 100%
• Unwanted Effects 66%
• Cytokine Therapy 66%
• Host Response 66%
• Periodontal Therapy 66%
• Periodontitis 66%
• Subantimicrobial Dose Doxycycline 66%
• Randomized Controlled Trial 33%
• Small Molecules 33%
• Routine Clinical Practice 33%
• Drug Therapy 33%
• Clinical Benefit 33%
• Non-steroidal Anti-inflammatory Drugs (NSAIDs) 33%
• Inflammatory Response 33%
• Significant Risk Factors 33%
• Nonselective Nonsteroidal Anti-inflammatory Drugs 33%
• Cyclooxygenase-2 Inhibitors 33%
• Rheumatoid Arthritis Treatment 33%
• Human Trials 33%
• Periodontal Disease 33%
• Host Inflammatory Response 33%
• Matrix Metalloproteinase Inhibitors 33%
• Adjunctive Therapy 33%
• Novel Host 33%
• Alveolar Bone Resorption 33%
• Treatment Concept 33%
• Pro-resolving Lipid Mediators 33%

Medicine and Dentistry

• Antiinflammatory Agent 100%
• Periodontitis 100%
• Serositis 40%
• Doxycycline 40%
• Immune Response 40%
• Nonsteroid Antiinflammatory Agent 40%
• Cytokine Therapy 40%
• Randomized Controlled Trial 20%
• Matrix Metalloproteinase 20%
• Health Care Cost 20%
• Drug Therapy 20%
• Mediator 20%
• Cyclooxygenase 2 Inhibitor 20%
• Rheumatoid Arthritis 20%
• Edentulism 20%
• Biological Molecule 20%
• Periodontal Treatment 20%
• Alveolar Bone Resorption 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Antiinflammatory Agent 100%
• Periodontitis 100%
• Cytokine 40%
• Doxycycline 40%
• Inflammation 40%
• Non-Steroidal Anti-Inflammatory Drug 40%
• Pharmacotherapy 20%
• Randomized Controlled Trial 20%
• Rheumatoid Arthritis 20%
• Biological Product 20%
• Periodontal Disease 20%
• COX-2 Inhibitor 20%
• Matrix Metalloproteinase 20%